The HinduKols in UP: A life without rightsThe HinduOver the years, a large number have contracted lung diseases like silicosis and tuberculosis. Some have lost limbs or sustained crippling injuries during the blasting of the rocks. Pannalal Kol, 60, wh…
Compulsory licensing – where is India heading? – IAM (blog) (registration)
|
Compulsory licensing – where is India heading?
IAM (blog) (registration) … were initiated in 2007 by Natco against Pfizer’s drug Sutent (Sunitinib) (see “India to hear patentees’ view in compulsory license cases”), which was used to treat gastrointestinal stromal tumours and Roche’s Tarceva, used in lung cancer treatment. |
Death notices for April 10 – Tulsa World
|
Death notices for April 10
Tulsa World Pawnee – Teresa Louise “Lo” Horsechief, 46, Bureau of Indian Affairs human resources specialist, died Monday in Tulsa. Service 1 p.m. Thursday, Pawnee Nation Roam Chief Center. Poteet. Perry – Elizabeth (Treeman) … In an effort to honor those who … |
BioLineRx Receives Regulatory Approval to Commence Phase II Clinical Trial … – PharmiWeb.com (press release)
BioLineRx Receives Regulatory Approval to Commence Phase II Clinical Trial …PharmiWeb.com (press release)Pre-clinical studies show that BL-8040 is efficient both alone and in combination with the anti-cancer drug Rituximab in reducing bone marrow met…
Immunomedics Develops T-Cell Redirecting Bispecific Antibodies as Potential … – NASDAQ
Immunomedics Develops T-Cell Redirecting Bispecific Antibodies as Potential …NASDAQThe use of bispecific antibodies to redirect T cells for the killing of targeted tumor cells has shown considerable promise both preclinically and clinically. The Comp…
Immunomedics Develops T-Cell Redirecting Bispecific Antibodies as Potential … – Benzinga
Immunomedics Develops T-Cell Redirecting Bispecific Antibodies as Potential …BenzingaThe use of bispecific antibodies to redirect T cells for the killing of targeted tumor cells has shown considerable promise both preclinically and clinically. The Co…
Immunomedics Develops T-Cell Redirecting Bispecific Antibodies as Potential … – GlobeNewswire (press release)
Immunomedics Develops T-Cell Redirecting Bispecific Antibodies as Potential …GlobeNewswire (press release)The use of bispecific antibodies to redirect T cells for the killing of targeted tumor cells has shown considerable promise both preclinically a…
Immunomedics Develops T-Cell Redirecting Bispecific Antibodies as Potential … – MarketWatch (press release)
Immunomedics Develops T-Cell Redirecting Bispecific Antibodies as Potential …MarketWatch (press release)The use of bispecific antibodies to redirect T cells for the killing of targeted tumor cells has shown considerable promise both preclinically and…
Merck Announces FDA Acceptance of New Drug Application for an … – Business Wire (press release)
Merck Announces FDA Acceptance of New Drug Application for an …Business Wire (press release)Concomitant administration of NOXAFIL with cyclosporine or tacrolimus increases the whole blood trough concentrations of these calcineurin inhibitors. Nephrot…
Merck Announces FDA Acceptance of New Drug Application for an … – MarketWatch (press release)
Merck Announces FDA Acceptance of New Drug Application for an …MarketWatch (press release)Concomitant administration of NOXAFIL with cyclosporine or tacrolimus increases the whole blood trough concentrations of these calcineurin inhibitors. Nephrotox…